Posttranscriptional down-regulation of small ribosomal subunit proteins correlates with reduction of 18S rRNA in RPS19 deficiency  by Badhai, Jitendra et al.
FEBS Letters 583 (2009) 2049–2053journal homepage: www.FEBSLetters .orgPosttranscriptional down-regulation of small ribosomal subunit proteins
correlates with reduction of 18S rRNA in RPS19 deﬁciency
Jitendra Badhai, Anne-Sophie Fröjmark, Hamid Reza Razzaghian, Edward Davey, Jens Schuster, Niklas Dahl *
Department of Genetics and Pathology, The Rudbeck Laboratory, Uppsala University, Dag Hammarskjölds Väg 20, SE-751 85 Uppsala, Sweden
a r t i c l e i n f o a b s t r a c tArticle history:
Received 17 March 2009
Revised 9 May 2009
Accepted 12 May 2009
Available online 18 May 2009
Edited by Ulrike Kutay
Keywords:
Diamond-Blackfan anemia (DBA)
Ribosomal protein S19
Haploinsufﬁciency
Ribosome biogenesis
Antibody0014-5793/$36.00  2009 Federation of European Bio
doi:10.1016/j.febslet.2009.05.023
* Corresponding author. Fax: +46 18 554 025.
E-mail address: niklas.dahl@genpat.uu.se (N. DahlRibosomal protein S19 (RPS19) is mutated in patients with Diamond-Blackfan anemia (DBA). We
hypothesized that decreased levels of RPS19 lead to a coordinated down-regulation of other ribo-
somal (r-)proteins at the subunit level. We show that small interfering RNA (siRNA) knock-down
of RPS19 results in a relative decrease of small subunit (SSU) r-proteins (S20, S21 and S24) when
compared to large subunit (LSU) r-proteins (L3, L9, L30 and L38). This correlates with a relative
decrease in 18S rRNA with respect to 28S rRNA. The r-protein mRNA levels remain relatively
unchanged indicating a post transcriptional regulation of r-proteins at the level of subunit
formation.
 2009 Federation of European Biochemical Societies. published by Elsevier B.V. All rights reserved.1. Introduction
Ribosomal proteins are fundamental components in cellular
metabolism and ribosome synthesis is critical for cell growth and
development. The ribosomal (r-)proteins are responsible for the
correct folding and cleavage of rRNA as well as for subunit assem-
bly [1]. The ﬁrst disease to be associated with mutations in a ribo-
somal protein is Diamond-Blackfan anemia (DBA; OMIM
#205900), a rare congenital bone marrow failure characterized
by decreased numbers or absence of erythroid precursor cells [2].
Approximately 25% of patients with DBA carry heterozygous muta-
tions in the ribosomal protein S19 (RPS19) gene [3] and other sub-
sets of patients were recently shown to carry mutations in
different r-protein genes [4–7]. Until now, a variety of mutations
in RPS19 have been described [8] some of which presumably result
in RPS19 haploinsufﬁciency [2,9]. Ribosome proﬁling of cells with
RPS19 insufﬁciency show a speciﬁc reduction of the small subunit
(SSU) [10,11] supporting RPS19 to be critical for formation of the
40S subunit. Furthermore, induced depletion of RPS19 by means
of small interfering RNAs (siRNA) [12] leads to a delay in pre-rRNA
maturation and a perturbed biosynthesis of the small ribosomal
subunit [10,11,13–15]. Thus, it has been suggested that insufﬁ-
ciency of one r-protein is rate limiting for subunit formation as this
requires stoichiometric amounts of structural components [16,17].chemical Societies. published by E
).Here, we report on the quantiﬁcation of different r-proteins in
(i) a TF-1-B cell model with inducible siRNA against RPS19 and
(ii) lymphoblastoid cell lines (LCL) derived from RPS19 deﬁcient
DBA patients. We used a set of newly obtained antibodies directed
against eight speciﬁc r-proteins to clarify mechanisms for the coor-
dinated and subunit speciﬁc regulation of r-protein levels. We also
quantiﬁed the corresponding mRNA levels as well as the levels of
18S rRNA to 28S rRNA. We show that siRNA against RPS19 signiﬁ-
cantly reduces the levels of other SSU r-proteins but not large sub-
unit (LSU) r-proteins. This correlates to a reduction in 18S rRNA
whereas the levels of small r-protein mRNAs are relatively unal-
tered. The patient derived LCL showed a skewed ratio of SSU to
LSU r-proteins that is similar but less marked to that observed after
RPS19 knock-down in TF-1 cells. Our combined data show that re-
duced levels of a single r-protein leads to a decrease in levels of
other r-proteins at the level of subunit formation. This is indepen-
dent of transcription of r-protein mRNAs and supports that subunit
imbalance is a critical pathophysiological mechanism in DBA.
2. Materials and methods
2.1. Cell culture, siRNA induction and Western blotting
The TF-1-B cell line was cultured as described and stably trans-
duced with inducible siRNA against RPS19 (kindly provided by Prof.
Stefan Karlsson, Lund, Sweden) [18]. siRNA expression was in-
duced using doxycycline and cells were harvested after 2, 4 andlsevier B.V. All rights reserved.
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were cultured in RPMI 1640 (GIBCO) supplemented with 10% fetal
bovine serum (GIBCO), 2 mM L-glutamine (GIBCO) and 20 IU/ml of
penicillin and streptomycin solution (GIBCO). TF-1-B cells and lym-
phoblastoid cells were lysed in RIPA buffer (50 mM Tris–HCl pH
7.5, 150 mM NaCl, 1% Triton X-100, 1% sodium deoxycholate and
0.1% SDS) supplemented with MG132 proteasome inhibitor (SIG-
MA), phosphatase inhibitor cocktail 1 (SIGMA), 0.1 mM sodium
vanadate (SIGMA) and protease inhibitor cocktail (SIGMA). Cell
debris was removed by centrifugation at 13 000g for 10 min at
4 C and the supernatant was collected. Cell lysates were separated
on a 10% Bis–Tris SDS–PAGE (NuPage gel; Invitrogen), and trans-
ferred to PVDF Immobilon-FL membranes (Millipore) according
to manufacturer’s protocols. The membranes were hybridized with
primary antibodies against eight ribosomal proteins as well as
ﬁbrillarin (Abcam) and b-actin (Abcam). Proteins detected by the
antibodies were visualized using Alexa Fluor 680 (a-rabbit, a-goat)
and IRDye 800 labeled (a-mouse) secondary antibodies (Molecular
Probes and LiCor Bioscience, respectively). Western blots were
analyzed using the Odyssey infrared imaging system, determin-
ing integrated intensities for each protein following the instruc-
tions manual (Li-Cor Bioscience). The relative amounts of
proteins were estimated after normalization to the intensity of b-
actin within the same cell line. At least two independent measure-
ments were performed.
2.2. Quantitative RT/PCR (qRT/PCR) and rRNA quantiﬁcation
Total RNA was isolated from induced and non-induced TF-1-B
cells and LCL using Trizol reagent (Invitrogen). The 18S and 28S
rRNAs were quantiﬁed using the Agilent RNA 6000 nano kit and
the Agilent 2100 bioanalyser according to manufacturer’s instruc-
tions. cDNA was synthesized with M-MULV reverse transcriptase
(MBI Fermentas) using random hexamer primers and 2 lg of total
RNA following the manufacturer’s recommendations. Quantitative
real-time PCR was performed in triplicates using platinum SYBR
green qPCR supermix UDG (Invitrogen) according to the protocol
supplied by the manufacturer.
2.3. Antibodies
Antibodiesagainsteighthumanr-proteinsusedwereraised inrab-
bits by the SwedishHumanProteinResource (HPR)program [19]. The
followingantibodieswith theirHPRdesignationswereused:a-RPS19
(HPRK580005); a-RPS20 (HPA003570); a-RPS21 (HPA003371); a-
RPS24 (HPA003364); a-RPL3 (HPA003365); a-RPL9 (HPA003372);
a-RPL30 (HPA002651) and a-RPL38 (HPRK580013).
2.4. Statistical analysis
The results obtained from Western blots or qRT/PCR are dis-
played as mean ± standard deviation. The two tailed Student’s t-
test was employed to compare expression levels of individual r-
proteins, mRNAs and ratios.α-S21
α-S20
α-S24 α-L38
α-L30
α-L9
Fig. 1. Levels of r-proteins after siRNA induced knock-down of RPS19 in TF-1-B cells
for 7 days. Western blot analysis of induced (dox+) and non-induced (dox) TF-1-B
cells, respectively, using the primary antibodies targeting r-proteins, b-actin and
ﬁbrillarin. Doxycycline induction results in a reduction of S19 r-protein levels to
30% of levels in non-induced cells (S; small subunit protein: L; large subunit
protein. Pictures of the complete Western blots are presented in Supplementary
Fig. 1).3. Results and discussion
3.1. siRNA-mediated knock-down of RPS19 results in reduced levels of
SSU r-proteins and 18S rRNA but not in levels of SSU r-protein mRNAs
Approximately 25% of patients with Diamond-Blackfan anemia
carry heterozygous mutations in RPS19 some of which presumably
result in haploinsufﬁciency [8,9]. The molecular mechanisms med-
iated by r-protein haploinsufﬁciency are not fully understood but it
has been shown that r-protein deﬁcient cells accumulate rRNAprecursors and show a perturbed formation of ribosomal subunits
[10,11,20]. We obtained a set of eight novel antibodies directed
against human r-proteins to study their expression in cell systems
with reduced levels of r-protein S19 [19]. The erythroleukemia de-
rived cell line TF-1-B was induced by doxycycline to express siRNA
targeted against the 30-end of the RPS19 mRNA [18]. The model al-
lows for a marked down-regulation of S19 after siRNA induction
and thereby for the detection of subtle effects in S19 deﬁciency
[18]. We analyzed the levels of RPS19 mRNA and r-protein S19
after 2, 4 and 7 days of induction in TF-1-B cells (Fig. 1 and Supple-
mentary Figs. 1 and 2). We observed that the siRNA mediated
knock-down of RPS19 leads to a gradual decrease of S19 levels with
the most pronounced effect after 7 days. Cells induced with doxy-
cycline for 7 days showed RPS19 mRNA at levels approximately 5%
of that in non-induced cells (qPCR; data not shown) and RPS19
protein at levels approximately 30% of that in non-induced cells
(Fig. 1 and Supplementary Fig. 1). This conﬁrms a marked knock-
down of S19 as previously observed in TF-1-B cells [18]. The
induced cellswere subsequently analyzed formRNA and protein lev-
els of three additional r-proteins from the SSU (S20, S21 and S24)
and four r-proteins from the LSU (L3, L9, L30 and L38) by quantita-
tive RT/PCR andWestern blotting (Fig. 1 and Supplementary Fig. 1).
The mRNA levels for the seven r-proteins in induced cells did not
show signiﬁcant changes when compared to non-induced cells
with the exception of RPL3 (Fig. 2A). However, the protein levels
of the three SSU r-proteins were signiﬁcantly reduced when S19
was down-regulated (Fig. 2B). The three SSU r-proteins were re-
duced to approximately 30% of normal levels and similar to the
reduction of S19 levels. siRNA induced knock-down of RPS19 was
not associated with a signiﬁcant reduction in levels of LSU r-pro-
teins although a tendency was observed for three of the four LSU
r-proteins (Fig. 2B). The mRNA and protein levels of ﬁbrillarin, used
as marker for general protein synthesis, were not changed after
siRNA induction against RPS19 (Figs. 1 and 2). The marked decrease
in levels of SSU r-proteins with respect to LSU r-proteins results in
a signiﬁcantly skewed ratio of SSU to LSU r-proteins (Fig. 2C).
A previous study has used siRNA against RPS19 in HeLa cells for
the subsequent analysis of r-protein levels [21]. In this study a sin-
gle LSU protein (L26) was analyzed suggesting unchanged levels in
response to RPS19 knock down. It is known that ribosome biosyn-
thesis, at least in part, is regulated at the transcriptional level
[22,23] and the turnover of r-protein mRNAs is assumed to occur
quite rapidly [15]. Our observations showing a marked down-reg-
ulation of SSU r-proteins but not their mRNAs imply a post tran-
scriptional event.
The ribosome comprises four rRNAs and approximately 80 dif-
ferent r-proteins. The r-proteins are structural components of the
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Fig. 2. Levels of mRNA and protein corresponding to seven r-proteins and ﬁbrillarin
(Fib) after siRNA mediated knock-down of RPS19 (7 days of induction). Three SSU r-
proteins (S) and four LSU proteins (L) are analyzed. (A) Amounts of mRNA levels in
doxycycline induced TF-1-B cells related to the amounts in non-induced cells (set to
1.0). A signiﬁcant down-regulation was observed for RPL3 mRNA only (* denotes
P < 0.05; three independent experiments). Quantiﬁcation was performed by qRT/
PCR (primer sequences are available upon request) and normalized to b-actin. (B)
Amounts of r-protein in doxycycline induced TF-1-B cells related to the amounts in
uninduced cells (set to 1.0) as determined by western blot analysis using speciﬁc
antibodies. A signiﬁcant reduction was observed for the three SSU r-proteins
(* denotes P < 0.05; three independent experiments) but not for any of the LSU r-
proteins using two tailed Student’s t-test. (C) Ratio of pooled SSU r-protein levels to
pooled LSU r-protein levels in non-induced TF-1-B cells (set to 1.0) and induced TF-
1-B cells, respectively (* denotes P < 0.05; two tailed Student’s t-test). The levels of
individual r-proteins are normalized to b-actin and averaged before pooling.
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Fig. 3. Amounts of 18S rRNA to 28S rRNA in TF-1-B cells after siRNA mediated
knock-down of RPS19. Total RNA was isolated from doxycycline induced and
uninduced TF-1-B cells after 2, 4 and 7 days, respectively. The amounts of rRNAs
were quantiﬁed using the Agilent 2100 bioanalyser. (A) The 18S to 28S rRNA ratio in
induced cells as compared to uninduced cells set to 1 (* denotes P < 0.05; two tailed
Student’s t-test). (B) The mean values of the 18S to 28S ratio in uninduced (dox)
and induced (dox+) cells at day 2, 4 and 7 with standard deviations. The mean
values at each day is based on three different experiments.
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the ribosomal subunits. It is assumed that the appropriate amounts
and stoichiometry of r-proteins is maintained during the assembly
of free r-proteins into the 40S and 60S subunits respectively andexcess proteins are degraded during this process [23]. This mecha-
nism would explain the marked down-regulation of the SSU r-pro-
teins in the siRNA induced TF-1-B cells, resulting in a skewed SSU
to LSU r-protein ratio (Fig. 2C). To investigate whether the ob-
served SSU r-protein down-regulation can be ascribed to a de-
crease in the SSU, we quantiﬁed the amounts of 18S rRNA with
respect to 28S rRNA in induced and uninduced TF-1-B cells. The ra-
tio of 18S to 28S rRNA decreased gradually from day 2–7 after
induction when compared to uninduced cells (Fig. 3). After 7 days
of induction the ratio of 18S to 28S rRNA was reduced to 57%. This
suggests that the SSU turnover can explain a substantial part of the
simultaneous down-regulation of SSU r-proteins which was 30% of
that observed in non-induced cells (Fig. 2B). However, the com-
bined results suggest that additional mechanisms may contribute
to the co-regulation of SSU r-protein levels independently of the
rRNA levels and subunit assembly.
The observed skewed ratio of SSU to LSU r-proteins would the-
oretically result in reduced amounts of functional ribosomes and a
reduced translational capacity. Such a general effect on protein
synthesis has been reported in LCL derived from DBA patients
[24]. However, we did not detect any alteration in non-ribosomal
protein levels from the analysis of ﬁbrillarin and b-actin. Surpris-
ingly, RPS19 knock-down seems to result in a slight but non-signif-
icant down-regulation of three LSU r-proteins. The biosynthesis of
the LSU proceeds independently of the SSU and no mechanism is
yet known which adjusts levels of LSU r-proteins to SSU r-proteins.
One possible explanation is that the marked depletion of RPS19
(30% of normal) after siRNA induction leads to a relative adaptation
of LSU protein levels.
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Fig. 4. Ratio of pooled SSU r-protein levels to pooled LSU r-protein levels in
lymphoblastoid cell lines (LCL) from healthy controls and RPS19 deﬁcient DBA
patients. The ratio in LCL from healthy controls (left) is signiﬁcantly higher than
that in DBA patients with RPS19 mutations (right; * denotes P < 0.05). The levels of
individual r-proteins are normalized to b-actin and averaged before pooling. The
ratio in controls is set to 1.0.
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show a skewed ratio of SSU to LSU r-proteins
We next asked whether cells with heterozygous RPS19 muta-
tions derived from DBA patients show a skewed SSU/LSU ratio sim-
ilar to that observed in cells subjected to siRNA knock-down of
RPS19. Lymphoblastoid cell lines (LCL) from four patients carrying
different mutations in the RPS19 gene (patient 1 with a 5’splice site
mutation (c.411+1G>A); patient 2 with a start codon mutation
(c.1A>G); patient 3 with a 3.3 Mb deletion spanning the entire gene
[25]; patient 4 with an insertion in exon 3 (c.104_105insA)) and
LCL from three healthy controls were analyzed by both qRT/PCR
andWestern blotting. The four mutations associated with DBA pre-
dict a truncated S19 or haploinsufﬁciency for S19. Analysis using
qRT/PCR revealed a signiﬁcant down-regulation in the levels of
mRNA for RPS19 and RPS21 in mutant LCL when compared to con-
trol cells. The levels of the other six mRNAs encoding r-proteins
were not altered (Supplementary Fig. 3A). We were unable to de-
tect any signiﬁcant differences in the 18S to 28S ratio when com-
paring mutant to non-mutant LCL.
When analyzing the r-proteins we could not detect any signiﬁ-
cant reduction of individual r-protein levels in RPS19 mutant cell
lines when compared to controls (Supplementary Fig. 3B) with
the eight speciﬁc r-protein antibodies. A tendency towards reduced
levels was observed for RPS21 and RPS24 but this was non-signif-
icant. One possible explanation for this ﬁnding is a large variation
in expression of individual r-proteins which we observe when
comparing the cell lines. It may also be hypothesized that the alle-
lic haploinsufﬁciency due to RPS19 mutations results in a relative
reduction in levels of RPS19 rather than haploinsufﬁency because
of post transcriptional compensatory mechanisms. However, we
then pooled the r-protein levels from SSU and LSU, respectively
and the ratio of SSU/LSU levels were compared between LCL from
patients and controls. This revealed a signiﬁcant reduction of the
SSU to LSU r-protein ratio in cells carrying RPS19 mutations
(P < 0.05; Fig. 4). Although signiﬁcant, the effect of heterozygous
RPS19mutations on SSU/LSU ratio is less marked in LCL when com-
pared to the TF-1-B cell model (Fig. 2C).
In summary, we obtained eight antibodies which provide a new
and sensitive tool for the analysis of r-protein expression in modelsystems for DBA. Our combined ﬁndings imply that RPS19 deﬁ-
ciency results in a down-regulation of other r-proteins from the
same subunit. This down-regulation does not correlate with mRNA
levels but partly with a reduction in 18S rRNA. The ﬁndings predict
subunit assembly to be one major mechanism in the co-regulation
of r-protein levels. However, our results also imply other contribut-
ing posttranscriptional mechanisms in the coordination of r-pro-
tein levels.
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